Reference is made to the stock exchange notice from Aqua Bio Technology ASA ("ABTEC" or the "Company") published on 13 March 2026 regarding the Extraordinary General Meeting approving a NOK 50 million debt conversion with the issuance of 10,000,000 new shares (the "New Shares") in the Company, at a subscription price of NOK 5.00 per New Share (the "Debt Conversion").

Expo Holding AS, a close associate of ABTEC board member Tonje Blaker, has subscribed for and been allocated 1,891,892 New Shares in the Debt Conversion. Following this and upon completion of the Debt Conversion, Expo Holding AS holds 2,156,763  shares in the Company.

Please see the attached notification form for further information.

This information is subject to the disclosure requirements pursuant to MAR article 19.

Contacts
Kristian Flaten
CEO & CFO
Aqua Bio Technology ASA

Phone: +47 9509 2322
Email: kf@aquabiotech.no

About Us
Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in skincare and nonfood. The group has distribution towards B2C and B2B, and offers freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-03-16 23:33 CET.

Attachments
Aqua Bio Technology ASA: Primary insider notification
260316 ABTEC KRT 1500 Expo Holding AS

Läs mer på MFN